• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PFIZER CONSUMER HEALTH CARE THERMACARE LOWER BACK & HIP; DISPOSABLE PACK, HOT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PFIZER CONSUMER HEALTH CARE THERMACARE LOWER BACK & HIP; DISPOSABLE PACK, HOT Back to Search Results
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Rash (2033); Urticaria (2278)
Event Date 03/12/2017
Event Type  Injury  
Event Description
Rash/burn turned out to be the beginning of shingles [herpes zoster], did not check skin under the product while wearing thermacare/the patient did read the instructions to know how long to wear the heatwrap [intentional device misuse], hives on arms, hands, legs, belly [urticaria].Case narrative: this is a spontaneous report from a contactable consumer.A (b)(6) female patient (not pregnant) started to use thermacare heatwrap (thermacare lower back & hip) on (b)(6) 2017 for pain in lower back right side.The patient's medical history was not reported.The patient's concomitant medications were none.The patient previously used thermacare heatwrap for unknown indication with no issues.On (b)(6) 2017, the patient reported "what do i need to put on a rash/burn from this wrap? are there any directions for care in case of burn/rash? the package & all has already gone out in our trash.It was a size small lower back/hip band.I didn't even think to save it for you for testing".The patient used the heatwrap for 3 hours and did not check the skin under the heatwrap while wearing on (b)(6) 2017.When she removed it, it left large red burn/rash marks.The patient took a shower to try to clean off whatever may have caused it, but was not hospitalized and did not receive any treatment in response to the event burn/rash.Upon follow-up received on (b)(6) 2017, the patient reported the rash/burn turned out to be the beginning of shingles on (b)(6) 2017.The patient was hospitalized on an unspecified date in 2017 in response to the event shingles and treatment included tylenol for pain.The patient reported experiencing "hives randomly" occurring 1-2 times daily on arms, hands, legs, and belly since (b)(6) 2017.Treatment for hives included allergy 24 hr and benadryl cream.The patient described skin tone as very light or fair, no sensitive skin or abnormal skin conditions.She did not engage in exercise while using the product and did not take any medication during the time the problem/symptom was experienced.The patient did read the instructions to know how long to wear the heatwrap.Action taken for the product was permanently withdrawn.Clinical outcome of hives is not resolved.The outcome of the other events is unknown.Additional information has been requested and will be provided as it becomes available.Follow-up (24-apr-2017): new information received from a contactable consumer includes: suspect product indication and reaction data (additional event of shingles).Follow-up (15-may-2017): new information from a contactable consumer includes: patient details, past product use, product dosage regimen, action taken, event onset and stop dates, hospitalization required for shingles, therapeutic measures, additional events (hives and device use error) and event outcome.Follow-up (31-may-2017).New information received from a contactable consumer included: deny of concomitant medications.Follow up attempts completed.No further information is expected.Follow-up (28-oct-2019): this follow-up report is being submitted to upgrade this case to a reportable mdr.Company clinical evaluation comment: based on the information provided, the event "rash/burn turned out to be the beginning of shingles" with hospitalization and "intentional device misuse" as described in this case are considered as serious bodily injury requiring medical intervention to prevent permanent damage or impairment of body structure.The event "hive" is non-serious.The events are assessed as associated with the use of the device.Comment: based on the information provided, the event "rash/burn turned out to be the beginning of shingles" with hospitalization and "intentional device misuse" as described in this case are considered as serious bodily injury requiring medical intervention to prevent permanent damage or impairment of body structure.The event "hive" is non-serious.The events are assessed as associated with the use of the device.
 
Event Description
Event verbatim [preferred term] rash/burn turned out to be the beginning of shingles [herpes zoster] , did not check skin under the product while wearing thermacare/the patient did read the instructions to know how long to wear the heatwrap [intentional device misuse] , hives; on arms, hands, legs, belly [urticaria].Case narrative:this is a spontaneous report from a contactable consumer.A 38-year-old female patient (not pregnant) started to use thermacare heatwrap (thermacare lower back & hip) on (b)(6)2017 for pain in lower back right side.The patient's medical history was not reported.The patient's concomitant medications were none.The patient previously used thermacare heatwrap for unknown indication with no issues.On (b)(6)2017, the patient reported "what do i need to put on a rash/burn from this wrap? are there any directions for care in case of burn/rash? the package & all has already gone out in our trash.It was a size small lower back/hip band.I didn't even think to save it for you for testing".The patient used the heatwrap for 3 hours and did not check the skin under the heatwrap while wearing on (b)(6)2017.When she removed it, it left large red burn/rash marks.The patient took a shower to try to clean off whatever may have caused it, but was not hospitalized and did not receive any treatment in response to the event burn/rash.Upon follow-up received on 24apr2017, the patient reported the rash/burn turned out to be the beginning of shingles on (b)(6)2017.The patient was hospitalized on an unspecified date in 2017 in response to the event shingles and treatment included tylenol for pain.The patient reported experiencing "hives randomly" occurring 1-2 times daily on arms, hands, legs, and belly since (b)(6)2017.Treatment for hives included allergy 24hr and benadryl cream.The patient described skin tone as very light or fair, no sensitive skin or abnormal skin conditions.She did not engage in exercise while using the product and did not take any medication during the time the problem/symptom was experienced.The patient did read the instructions to know how long to wear the heatwrap.Action taken for the product was permanently withdrawn.Clinical outcome of hives is not resolved.The outcome of the other events is unknown.Product quality complaints provided the following investigation results: the sample status at the site was not received.This investigation was conducted for an unknown lot number lower back/hip (lbh) 8-hour product.The root cause category is non-assignable (complaint not confirmed as a quality defect).There was limited device specific information provided, no batch number or return sample was available for evaluation.Without a batch reference number and/or return sample a manufacturing and technical evaluation cannot be completed for the wrap involved in this case.There is not a product quality related trend identified for the subclass adverse event safety request for investigation.The manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.There was no reasonable suggestion of device malfunction.Follow-up (24apr2017): new information received from a contactable consumer includes: suspect product indication and reaction data (additional event of shingles).Follow-up (15may2017): new information from a contactable consumer includes: patient details, past product use, product dosage regimen, action taken, event onset and stop dates, hospitalization required for shingles, therapeutic measures, additional events (hives and device use error) and event outcome.Follow up (31may2017).New information received from a contactable consumer included: deny of concomitant medications.Follow up attempts completed.No further information is expected.Follow-up (28oct2019): this follow-up report is being submitted to upgrade this case to a reportable mdr.Follow-up (19mar2020): new information received from a product quality complaint group includes: investigation results.Follow up attempts completed.No further information is expected.Comment: based on the information provided, the event "rash/burn turned out to be the beginning of shingles" with hospitalization and "intentional device misuse" as described in this case are considered as serious bodily injury requiring medical intervention to prevent permanent damage or impairment of body structure.The event "hive" is non-serious.The events are assessed as associated with the use of the device.There was limited device specific information provided, no batch number or return sample was available for evaluation.Without a batch reference number and/or return sample a manufacturing and technical evaluation cannot be completed for the wrap involved in this case.Product effect varies with each individual.In the case narrative, there is evidence of "intentional device misuse" which most likely contributed to this incident.No remedial action/corrective action/field safety corrective action is suggested at this time.
 
Manufacturer Narrative
The sample status at the site was not received.This investigation was conducted for an unknown lot number lower back/hip (lbh) 8-hour product.The root cause category is non-assignable (complaint not confirmed as a quality defect).There was limited device specific information provided, no batch number or return sample was available for evaluation.Without a batch reference number and/or return sample a manufacturing and technical evaluation cannot be completed for the wrap involved in this case.There is not a product quality related trend identified for the subclass adverse event safety request for investigation.The manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.There was no reasonable suggestion of device malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMACARE LOWER BACK & HIP
Type of Device
DISPOSABLE PACK, HOT
Manufacturer (Section D)
PFIZER CONSUMER HEALTH CARE
1231 wyandotte drive
albany GA 31705
MDR Report Key9387932
MDR Text Key185300837
Report Number1066015-2019-00502
Device Sequence Number1
Product Code IMD
Combination Product (y/n)N
PMA/PMN Number
K953442
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 03/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/27/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/01/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age38 YR
Patient Weight63
-
-